We could not find any results for:
Make sure your spelling is correct or try broadening your search.
GRAIL is a healthcare company innovating to solve medicine's most important challenges. The Company's team of leading scientists, engineers and clinicians are on an urgent mission to detect cancer early, when it may be more treatable and potentially curable. GRAIL is a healthcare company innovating to solve medicine's most important challenges. The Company's team of leading scientists, engineers and clinicians are on an urgent mission to detect cancer early, when it may be more treatable and potentially curable.
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire MENLO PARK, Calif., Dec. 3, 2024 MENLO PARK, Calif., Dec. 3, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a...
GRAIL to Participate in Upcoming Investor Conferences PR Newswire MENLO PARK, Calif., Nov. 19, 2024 MENLO PARK, Calif., Nov. 19, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare...
GRAIL Announces First Patient Tested With Blood-Based Assay in Global Phase 3 Adjuvant Lung Cancer Study PR Newswire MENLO PARK, Calif., Nov. 18, 2024 MENLO PARK, Calif., Nov. 18, 2024 ...
GRAIL Reports Third Quarter 2024 Financial Results PR Newswire MENLO PARK, Calif., Nov. 12, 2024 Galleri Revenue Grew 52% Year-Over-Year to $25.4 Million Commercial Galleri Sales Surpassed...
GRAIL to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum PR Newswire MENLO PARK, Calif., Nov. 4, 2024 MENLO PARK, Calif., Nov. 4, 2024 /PRNewswire/...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.28 | 6.29921259843 | 20.32 | 23.44 | 20.23 | 1019817 | 21.49098919 | CS |
4 | 5.6 | 35 | 16 | 23.44 | 13.58 | 863668 | 18.41947605 | CS |
12 | 7.41 | 52.2198731501 | 14.19 | 23.44 | 12.33 | 712623 | 15.7072752 | CS |
26 | 2.97 | 15.9420289855 | 18.63 | 23.44 | 12.33 | 1069366 | 15.76140317 | CS |
52 | 2.97 | 15.9420289855 | 18.63 | 23.44 | 12.33 | 1069366 | 15.76140317 | CS |
156 | 2.97 | 15.9420289855 | 18.63 | 23.44 | 12.33 | 1069366 | 15.76140317 | CS |
260 | 2.97 | 15.9420289855 | 18.63 | 23.44 | 12.33 | 1069366 | 15.76140317 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions